APA (7th ed.) Citation

Clark, P. E., Taparra, K., & Miller, J. A. (2024). Identification of High-Incidence Populations in the United States for Anti-Epstein-Barr Virus Serologic Screening for Nasopharyngeal Carcinoma. Cancer Epidemiology, Biomarkers & Prevention, 33(12), 1706. https://doi.org/10.1158/1055-9965.EPI-24-0576

Chicago Style (17th ed.) Citation

Clark, Payton E., Kekoa Taparra, and Jacob A. Miller. "Identification of High-Incidence Populations in the United States for Anti-Epstein-Barr Virus Serologic Screening for Nasopharyngeal Carcinoma." Cancer Epidemiology, Biomarkers & Prevention 33, no. 12 (2024): 1706. https://doi.org/10.1158/1055-9965.EPI-24-0576.

MLA (9th ed.) Citation

Clark, Payton E., et al. "Identification of High-Incidence Populations in the United States for Anti-Epstein-Barr Virus Serologic Screening for Nasopharyngeal Carcinoma." Cancer Epidemiology, Biomarkers & Prevention, vol. 33, no. 12, 2024, p. 1706, https://doi.org/10.1158/1055-9965.EPI-24-0576.